Sphingomyelin Synthase 2
SGMS2geneSGMS2 regulates ceramide and sphingomyelin metabolism, affecting lipoprotein atherogenicity and subendothelial lipid accumulation.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleRemodels sphingomyelin and ceramides; dysregulation affects lipoprotein composition and atherogenicity.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000164023
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Lipidomics reveals the dysregulated ceramide metabolism in oxidized low-density lipoprotein-induced macrophage-derived foam cell.Biomedical chromatography : BMC · 2021 · PMID 34893994 · doi